Predictive Oncology's EBIT per Share for the
three
months ended in Mar. 2025 was $-0.32.
Its EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2025 was $-1.68.
During the past 3 years, the average EBIT per Share Growth Rate was 25.80% per year.
During the past 5 years, the average EBIT per Share Growth Rate was 51.50% per year.
During the past 10 years, the average EBIT per Share Growth Rate was 57.00% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for Predictive Oncology's EBIT per Share or its related term are showing as below:
POAI'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: 25.8 Med: 62.6 Max: 69.7
Current: 25.8
During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of Predictive Oncology was 69.70% per year. The lowest was 25.80% per year. And the median was 62.60% per year.
POAI's 3-Year EBIT Growth Rate is ranked better than 76.85% of 717
companies
in the Medical Devices & Instruments industry
Industry Median: 7.4
vs POAI: 25.80
Predictive Oncology EBIT per Share Historical Data
The historical data trend for Predictive Oncology's EBIT per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1.68
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Predictive Oncology (NAS:POAI) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
Predictive Oncology EBIT per Share Related Terms
Thank you for viewing the detailed overview of Predictive Oncology's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.
Predictive Oncology Inc functions in the healthcare domain. The firm's reportable segments are Pittsburgh segment that provides services which include the application of AI using its proprietary biobank of 150,000+ tumor samples. It also creates proprietary 3D culture models used in drug development; Birmingham segment that provides contract services and research focused on solubility improvements, stability studies, and protein production; and Eagan segment that produces the FDA-cleared STREAMWAY System and associated products for automated medical fluid waste management and patient-to-drain medical fluid disposal. It derives maximum revenue from Eagan Segment.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
POAI has been successfully added to your 